Open access publisher BioMed Central, US, has announced the publication of the 1,000th article in the journal BMC Cancer. The journal is the second medical journal in the BMC-series to achieve this milestone in 2008, after BMC Public Health.
The 1,000th article 'Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases' by Birgit Gruenberger and colleagues from the Medical University Vienna reports that oxaliplatin-based chemotherapy can reduce the risk of recurrence after liver resection in patients treated for liver metastases arising from colorectal cancer. The article has already been accessed over 900 times.
BMC Cancer is an open access journal publishing original peer-reviewed research articles in all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, and controlled trials. The journal is indexed/tracked/covered by PubMed, MEDLINE, CAS, Scopus, EMBASE, Thomson Reuters (ISI) and Google Scholar.
